TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 45 filers reported holding TFF PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $636 | -25.5% | 1,816 | 0.0% | 0.00% | – |
| Q2 2023 | $854 | -38.2% | 1,816 | -9.9% | 0.00% | – |
| Q1 2023 | $1,381 | -83.7% | 2,016 | -75.0% | 0.00% | – |
| Q4 2022 | $8,459 | +5.7% | 8,056 | +298.2% | 0.00% | – |
| Q3 2022 | $8,000 | -79.5% | 2,023 | -70.9% | 0.00% | – |
| Q2 2022 | $39,000 | +50.0% | 6,963 | +64.4% | 0.00% | – |
| Q1 2022 | $26,000 | -39.5% | 4,236 | -9.5% | 0.00% | – |
| Q4 2021 | $43,000 | -8.5% | 4,680 | -22.7% | 0.00% | – |
| Q3 2021 | $47,000 | -83.3% | 6,051 | -79.3% | 0.00% | – |
| Q2 2021 | $281,000 | +20.6% | 29,209 | +69.8% | 0.00% | – |
| Q1 2021 | $233,000 | +2018.2% | 17,206 | +2166.9% | 0.00% | – |
| Q4 2020 | $11,000 | 0.0% | 759 | +28.0% | 0.00% | – |
| Q3 2020 | $11,000 | 0.0% | 593 | -71.2% | 0.00% | – |
| Q4 2019 | $11,000 | – | 2,062 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,058,823 | $19,556,000 | 9.92% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 220,666 | $4,076,000 | 4.24% |
| Mesirow Financial Investment Management, Inc. | 34,902 | $645,000 | 2.76% |
| Gagnon Advisors, LLC | 176,471 | $3,259,000 | 2.00% |
| Nantahala Capital Management | 2,032,988 | $37,549,000 | 1.15% |
| PRECEPT MANAGEMENT LLC | 235,294 | $4,346,000 | 1.07% |
| GAGNON SECURITIES LLC | 219,584 | $4,056,000 | 0.86% |
| Sepio Capital, LP | 84,560 | $1,562,000 | 0.17% |
| 683 Capital Management, LLC | 117,647 | $2,173,000 | 0.16% |
| SANDERS MORRIS HARRIS LLC | 21,326 | $340,000 | 0.09% |